1. Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999; 212:543–549. PMID:
10429716.
Article
2. Ellerbroek N, Holmes F, Singletary E, Evans H, Oswald M, McNeese M. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer. 1990; 66:1461–1467. PMID:
2207996.
Article
3. Jackson B, Scott-Conner C, Moulder J. Axillary metastasis from occult breast carcinoma: diagnosis and management. Am J Surg. 1995; 61:431–434.
4. Kemeny MM, Rivera DE, Terz JJ, Benfield JR. Occult primary adenocarcinoma with axillary metastases. Am J Surg. 1986; 152:43–47. PMID:
3728816.
Article
5. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001; 220:13–30. PMID:
11425968.
Article
6. American College of Radiology. BI-RADS: Breast Imaging Reporting and Data System Atlas(BI-RADS®) atlas. 2003. 4th ed. Reston: American College of Radiology.
7. Harvey JA, Fajardo LL, Innis CA. Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation. 1993 ARRS President's Award. AJR Am J Roentgenol. 1993; 161:1167–1172. PMID:
8249720.
Article
8. Majid AS, de Paredes ES, Doherty RD, Sharma NR, Salvador X. Missed breast carcinoma: pitfalls and pearls. Radiographics. 2003; 23:881–895. PMID:
12853663.
Article
9. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004; 233:830–849. PMID:
15486214.
Article
10. Dershaw DD. Morris EA, Liberman L, editors. Magnetic resonance imaging as a clinical tool. Breast MRI; Diagnosis and intervention. 2004. New York, NY: Springer;p. 256–264.
Article
11. Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol. 2000; 174:1079–1084. PMID:
10749254.
Article
12. Morris EA, Schwartz LH, Dershaw DD, van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997; 205:437–440. PMID:
9356625.
Article
13. Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E. MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol. 1999; 9:470–473. PMID:
10087118.
Article
14. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001; 220:31–39. PMID:
11425969.
Article
15. Zujewski J, Eng-Wong J. Sentinel lymph node biopsy in the management of ductal carcinoma in situ. Clin Breast Cancer. 2005; 6:216–222. PMID:
16137431.
Article
16. Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S. Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol. 2006; 94:426–430. PMID:
16967457.
Article
17. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer. 2003; 98:2105–2113. PMID:
14601079.
18. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993; 187:493–501. PMID:
8475297.
Article
19. Friedman P, Sanders L, Russo J, Sharo R, Swaminathan S, Smith R. Detection and localization of occult lesions using breast magnetic resonance imaging: initial experience in a community hospital. Acad Radiol. 2005; 12:728–738. PMID:
15935971.